EUVIMEDEUVIMED entdecken
Open Access

Putative PINK1/Parkin activators lower the threshold for mitophagy by sensitizing cells to mitochondrial stress

William M Rosencrans iD, Ryan W Lee iD, Logan McGraw iD, Ian Horsburgh iD, Ting-Yu Wang, Baiyi Quan iD, Diana Huynh, Jennifer A Johnston iD, David C Chan iD, Tsui-Fen Chou iD

Science Advances · 29.08.2025 · 11 (35)

DOI: 10.1126/sciadv.ady0240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 29.08.2025. Verfasst von William M Rosencrans und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. Hauptthemen laut MEDLINE: Mitophagy, Ubiquitin-Protein Ligases, Protein Kinases, Mitochondria. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The PINK1/Parkin pathway targets damaged mitochondria for degradation via mitophagy. Genetic evidence implicates impaired mitophagy in Parkinson’s disease, making its pharmacological enhancement a promising therapeutic strategy. Here, we characterize two mitophagy activators: a novel Parkin activator, FB231, and the reported PINK1 activator MTK458. Both compounds lower the threshold for mitochondrial toxins to induce PINK1/Parkin-mediated mitophagy. However, global proteomics revealed that FB231 and MTK458 independently induce mild mitochondrial stress, resulting in impaired mitochondrial function and activation of the integrated stress response, effects that result from PINK1/Parkin-independent off-target activities. We find that these compounds impair mitochondria by distinct mechanisms and synergistically decrease mitochondrial function and cell viability in combination with classical mitochondrial toxins. Our findings support a model whereby weak or “silent” mitochondrial toxins potentiate other mitochondrial stressors, enhancing PINK1/Parkin-mediated mitophagy. These insights highlight important considerations for therapeutic strategies targeting mitophagy activation in Parkinson’s disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyUbiquitin-Protein LigasesProtein KinasesMitochondriaStress, PhysiologicalHumansParkinson DiseaseCell SurvivalHeLa CellsPTEN-Induced Putative Kinase

Substanzen

Ubiquitin-Protein LigasesProtein KinasesPTEN-Induced Putative Kinaseparkin protein

Autor:innen und Institutionen

  • Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
  • National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
  • NysnoBio, Mill Valley, CA, USA.

ORCID-Profile: William M Rosencrans, Ryan W Lee, Logan McGraw, Ian Horsburgh, Baiyi Quan, Jennifer A Johnston, David C Chan, Tsui-Fen Chou

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Rosencrans, W. M., Lee, R. W., McGraw, L., Horsburgh, I., Wang, T. Y., Quan, B., Huynh, D., Johnston, J. A., Chan, D. C., & Chou, T. F. (2025). Putative PINK1/Parkin activators lower the threshold for mitophagy by sensitizing cells to mitochondrial stress. Science Advances, 11(35). https://doi.org/10.1126/sciadv.ady0240

Vancouver

Rosencrans WM, Lee RW, McGraw L, Horsburgh I, Wang TY, Quan B, et al. Putative PINK1/Parkin activators lower the threshold for mitophagy by sensitizing cells to mitochondrial stress. Science Advances. 2025;11(35). doi:10.1126/sciadv.ady0240

BibTeX
@article{Rosencrans2025,
  author = {Rosencrans, William M and Lee, Ryan W and McGraw, Logan and Horsburgh, Ian and Wang, Ting-Yu and Quan, Baiyi and Huynh, Diana and Johnston, Jennifer A and Chan, David C and Chou, Tsui-Fen},
  title = {Putative PINK1/Parkin activators lower the threshold for mitophagy by sensitizing cells to mitochondrial stress},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {35},
  doi = {10.1126/sciadv.ady0240}
}
Kostenlos starten →